Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPE pseudogene 3 (SNRPEP3) is a processed pseudogene related to the SNRPE gene, which encodes small nuclear ribonucleoprotein polypeptide E, a core component of the spliceosomal machinery involved in mRNA splicing. Pseudogenes like SNRPEP3 are genomic sequences similar to known genes but generally lack the ability to encode functional proteins, and there is no evidence of therapeutic targeting or physiological function for SNRPEP3 itself[5][6]. No known drugs, clinical biomarkers, or disease associations are directly attributed to SNRPEP3. This gene is not considered a therapeutic target, and its primary importance is for genomic annotation studies in comparative genomics[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNRPE pseudogene 3 (SNRPEP3).